Ask Aeroz

Type the question you actually came here with.

EU FMD · Hospital pharmacies

The EU FMD for hospital pharmacies.

Under the EU Falsified Medicines Directive, a hospital pharmacy verifies each pack's safety features and decommissions its unique identifier, and may do so at any time the pack is in the hospital's physical possession.

A hospital pharmacy verifies the safety features and decommissions each pack's identifier before the medicine reaches a patient, as a community pharmacy does. The difference is timing: a healthcare institution may do it at any time the pack is in its physical possession, as long as the pack is not sold in between, so many hospitals scan at goods-in. A member state may also let a wholesaler in the same legal entity scan on the hospital's behalf.

Reg. (EU) 2016/161Article 25Article 26Goods-in scanningIn force
Key facts · reviewed

EU FMD for hospital pharmacies, in three facts.

Reg. (EU) 2016/161 Articles 25 to 28 · decommission at any time in physical possession · same-entity wholesaler option · part packs verified on first opening.

What the rule requires

Same duty, flexible timing.

Verify and decommission before use

A hospital pharmacy verifies the safety features and decommissions each pack's identifier before the medicine is given to a patient.

Any time it is in your hands

A healthcare institution may verify and decommission at any time the pack is in its physical possession, provided no sale takes place between delivery and supply.

When a same-entity wholesaler scans

A member state may let hospitals skip the scan when the pack comes from a wholesaler in the same legal entity, that wholesaler verifies and decommissions it, no sale takes place between them and the pack is used within the institution.

Part packs

Where only part of a pack is supplied and its identifier is still active, the pack is verified and decommissioned when it is first opened.

The dates

The timeline, as it stands.

Hospital duties have applied since 9 February 2019 in most member states. The Commission's guidance for hospital settings confirms that decommissioning can happen at any time the pack is in the institution's possession, which lets hospitals scan at receipt rather than on the ward.

Hospital duties applysince 9 Feb 2019
Greek and Italian hospitals join the EU system9 Feb 2025
What to do now

Three moves that de-risk the deadline.

01 · Step

Pick one scan point

Goods-in, pharmacy store or ward: choose one and make it the rule, because decommissioning at two points causes false alerts.

02 · Step

Check what your state allows

Find out whether your member state uses the same-entity wholesaler option; it changes who scans.

03 · Step

Train for undo

A decommissioned pack can be reverted only under strict conditions and within a short window. Train staff before go-live, not after the first error.

How Aeroz fits

Proof that the pack on the ward is the one you received.

Hospitals decommission at receipt, then move packs through stores, theatres and wards. Aeroz keeps an identity on the item that can be checked at any of those points with a tap, so a pharmacist can show that the product given to a patient is the one that came through goods-in.

FAQ

EU FMD for hospital pharmacies, answered.

Do hospitals have to scan every pack under the FMD?

Yes, unless the member state uses the same-entity wholesaler option or another exemption applies. The scan can happen at any time the pack is in the hospital's physical possession.

Can a hospital decommission packs at goods-in?

Yes. The Commission's guidance says decommissioning may take place at any time the medicine is in the healthcare institution's physical possession, as long as no sale takes place between delivery and supply.

What about a pack opened for part use?

If only part of a pack is supplied and its identifier is still active, the pharmacy verifies and decommissions it when the pack is first opened.

Is a US hospital pharmacy covered by something similar?

In the US, a hospital pharmacy is a dispenser under DSCSA. The rules differ, but both expect product checks before a patient receives the medicine. See the DSCSA guide for hospital pharmacies.

Readiness audit

Know exactly where you stand, in 14 days.

A fixed-fee Aeroz audit maps your products against EU FMD verification and decommissioning in a hospital setting and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.

Fixed fee: Readiness Report $2,500, Readiness Audit $4,500 14-day written report No commitment to proceed